Home > Reports, Tools, & Publications > Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study

Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study

Lingyi Li, J. Antonio Aviña-Zubieta,Charles N. Bernstein, Gilaad G. Kaplan, Helen Tremlett, Hui Xie, Juan-Nicolás Peña-Sánchez, Ruth Ann Marrie, Mahyar Etminan
Neurology
October 28, 2022

The publication aims to compare the risk of multiple sclerosis in anti-tumor necrosis factor alpha users with non-users among rheumatic disease or inflammatory bowel disease patients.

Citation

Li L, Aviña-Zubieta JA, Bernstein C, Kaplan GG, Tremlett H, Xie H, Peña-Sánchez JN, Marrie RA, Etminan M. The Risk of Multiple Sclerosis Among Users of Anti-tumor Necrosis Factor Alpha in four Canadian provinces: A Population-Based Study. Neurology. 2022; (Published ahead).

https://doi.org/10.1212/WNL.0000000000201472